<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01861639</url>
  </required_header>
  <id_info>
    <org_study_id>WP1P003</org_study_id>
    <nct_id>NCT01861639</nct_id>
  </id_info>
  <brief_title>Stability of rTMS on Cognition and Brain Networks on Healthy Subjects.</brief_title>
  <official_title>Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) on Cognition and Brain Networks in Healthy Subjects in 2 Sessions 15 Days Apart</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Qualissima</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Qualissima</source>
  <brief_summary>
    <textblock>
      Episodic and working memory processes are the most affected cognitive domains in Alzheimer's&#xD;
      Disease (AD) and its early stage, Mild Cognitive Impairment (MCI).&#xD;
&#xD;
      Transcranial Magnetic Stimulation (TMS) is a unique tool to interfere with cognitive&#xD;
      processes by inducing &quot;virtual and transient lesions&quot;, mimicking those observed in MCI. It&#xD;
      has proven repeatedly its capacity to interfere with encoding-retrieval memory task. However,&#xD;
      to date, only few imaging data exist on the cerebral pathways involved in encoding memory&#xD;
      task. Moreover, the stability of TMS effects over time remains to be investigated. If proven&#xD;
      to be a stable interfering challenge, TMS could be used to investigate the potential&#xD;
      restoring effect of new medication in AD.&#xD;
&#xD;
      The study is the pilot study of a larger clinical trial which aims to prove the utility of&#xD;
      rTMS as a potential model for prediction of clinical efficacy using a combination of&#xD;
      cognitive and neuroimaging endpoints.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Timeframe of the IMI project couldn't be expended&#xD;
  </why_stopped>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Outputs of the memory task</measure>
    <time_frame>up to Day 15</time_frame>
    <description>outputs: number of correct answers during the retrieval event-related task (Hit rate) and the rate of false recognition of novel pictures (False Alarms rate).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>CANTAB task</measure>
    <time_frame>Day 1 and Day 15</time_frame>
    <description>CANTAB / Rapid Visual Information Processing (RVIP)&#xD;
CANTAB / Spatial Working Memory (SWM)&#xD;
CANTAB / Paired Associates Learning (PAL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gene expression</measure>
    <time_frame>Day 1</time_frame>
    <description>Interest genes expression will be investigated depending on the impact of TMS on behavioral and functional brain responses.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Imaging</measure>
    <time_frame>Day1 and Day 15</time_frame>
    <description>Functional MRI (Barcelona): modifications will be highlighted by changes in Blood Oxydation level Dependence (BOLD)signal patterns&#xD;
EEG (Marseille): modifications will be highlighted by changes in EEG markers</description>
  </secondary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Actual">158</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>ineffective rTMS - Active TBS - fMRI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Effective rTMS - Active TBS - fMRI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>ineffective rTMS - Sham TBS - fMRI</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Effective rTMS - Sham TBS - fMRI</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>ineffective rTMS - Active TBS - EEG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Effective rTMS - Active TBS - EEG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>ineffective rTMS - Sham TBS - EEG</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Effective rTMS - Sham TBS - EEG</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ineffective rTMS</intervention_name>
    <description>A 20Hz repetitive transcranial magnetic stimulation (rTMS) will be applied for 900 ms with an intensity of 90% of motor threshold. Active stimulation will be applied on the L-DLPFC compared to an ineffective stimulation.</description>
    <arm_group_label>ineffective rTMS - Active TBS - EEG</arm_group_label>
    <arm_group_label>ineffective rTMS - Active TBS - fMRI</arm_group_label>
    <arm_group_label>ineffective rTMS - Sham TBS - EEG</arm_group_label>
    <arm_group_label>ineffective rTMS - Sham TBS - fMRI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>active TBS</intervention_name>
    <description>A continuous Theta-Burst Stimulation (cTBS) protocol will be applied over the L-DLPFC. Three stimuli at 50Hz, 80% of individual Motor Threshold will be repeated every 200ms for 40sec</description>
    <arm_group_label>Effective rTMS - Active TBS - EEG</arm_group_label>
    <arm_group_label>Effective rTMS - Active TBS - fMRI</arm_group_label>
    <arm_group_label>ineffective rTMS - Active TBS - EEG</arm_group_label>
    <arm_group_label>ineffective rTMS - Active TBS - fMRI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham TBS</intervention_name>
    <description>A Sham stimulation will be applied over the L-DLPFC. a placebo coil will be used.</description>
    <arm_group_label>Effective rTMS - Sham TBS - EEG</arm_group_label>
    <arm_group_label>Effective rTMS - Sham TBS - fMRI</arm_group_label>
    <arm_group_label>ineffective rTMS - Sham TBS - EEG</arm_group_label>
    <arm_group_label>ineffective rTMS - Sham TBS - fMRI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>fMRI</intervention_name>
    <description>Functional MRI data will be acquired during the performance of the memory task. Functional data will be acquired with a blood oxygenation level dependant (BOLD) contrast sensitive gradient echo, T2*-weighted echo-planar imaging sequence</description>
    <arm_group_label>Effective rTMS - Active TBS - fMRI</arm_group_label>
    <arm_group_label>Effective rTMS - Sham TBS - fMRI</arm_group_label>
    <arm_group_label>ineffective rTMS - Active TBS - fMRI</arm_group_label>
    <arm_group_label>ineffective rTMS - Sham TBS - fMRI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EEG</intervention_name>
    <description>EEG will be coupled with task performance in an event-related manner to be able to isolate brain activity of each type of stimuli presented. EEG imaging data will be acquired during the memory task.</description>
    <arm_group_label>Effective rTMS - Active TBS - EEG</arm_group_label>
    <arm_group_label>Effective rTMS - Sham TBS - EEG</arm_group_label>
    <arm_group_label>ineffective rTMS - Active TBS - EEG</arm_group_label>
    <arm_group_label>ineffective rTMS - Sham TBS - EEG</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Effective rTMS</intervention_name>
    <description>A 20Hz repetitive transcranial magnetic stimulation (rTMS) will be applied for 900 ms with an intensity of 90% of motor threshold. Active stimulation will be applied on the L-DLPFC compared to an effective stimulation.</description>
    <arm_group_label>Effective rTMS - Active TBS - EEG</arm_group_label>
    <arm_group_label>Effective rTMS - Active TBS - fMRI</arm_group_label>
    <arm_group_label>Effective rTMS - Sham TBS - EEG</arm_group_label>
    <arm_group_label>Effective rTMS - Sham TBS - fMRI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Healthy male subjects aged between 18 and 40 years-old inclusive.&#xD;
&#xD;
          -  Education level: at least secondary.&#xD;
&#xD;
          -  Right-handed (Edinburgh Handedness Inventory).&#xD;
&#xD;
          -  The subjects are in good health on the basis of the medical interview (medical&#xD;
             history, symptoms), the physical examination and vital signs.&#xD;
&#xD;
          -  No history of psychiatric disorders (assessed by Structured Clinical Interview for DSM&#xD;
             IV Disorders (SCID) for Barcelona and by the Mini International Neuropsychiatric&#xD;
             Interview (MINI) for Marseille).&#xD;
&#xD;
          -  No history of neurological disorders&#xD;
&#xD;
          -  No history of concussion (cranial or facial trauma) without or with loss of&#xD;
             consciousness.&#xD;
&#xD;
          -  Subject without history of brain disease (severe brain trauma, stroke, cerebral&#xD;
             tumor...).&#xD;
&#xD;
          -  Subject without lesion on MRI.&#xD;
&#xD;
          -  Subject without abnormal electrical activities on standard clinical EEG.&#xD;
&#xD;
          -  No history of drug or alcohol abuse.&#xD;
&#xD;
          -  No smoker or ≤ 5 cg/ day.&#xD;
&#xD;
          -  The subject can complete the neuropsychological test battery during the training&#xD;
             session.&#xD;
&#xD;
          -  Subject without contraindication to MRI.&#xD;
&#xD;
          -  The subject is able to read and understand the Information Form and comply with the&#xD;
             protocol instructions and restrictions.&#xD;
&#xD;
          -  The subject is covered by a social insurance.&#xD;
&#xD;
          -  The subject has provided written informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History or presence of psychiatric illness (Psychiatric interview).&#xD;
&#xD;
          -  History or presence of neurologic illness.&#xD;
&#xD;
          -  The subject, in the opinion of the investigator, is unlikely to comply with the study&#xD;
             protocol or is unsuitable for any other reason.&#xD;
&#xD;
          -  The subject participates in another clinical trial or is still being within a washout&#xD;
             period of 1 month since last taking of a previous clinical trial, or subjects who have&#xD;
             received more than 4500 Euros in the previous 12 months for participating in clinical&#xD;
             trials.&#xD;
&#xD;
          -  Presence of metallic objects within the body.&#xD;
&#xD;
          -  Subjects with pacemaker.&#xD;
&#xD;
          -  Claustrophobia.&#xD;
&#xD;
          -  Individual and familial history of epileptic seizure.&#xD;
&#xD;
          -  Any medication listed (see annexe) in the safety guidelines published by the Safety of&#xD;
             TMS Consensus Group (Rossi et al., 2009) will be forbidden.&#xD;
&#xD;
          -  Subject with a correct hit rate during the retrieval session of the memory task&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Bartrés-Faz</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut d'Investigacions Biomèdiques August Pi i Sunyer</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christine Audebert</last_name>
    <role>Principal Investigator</role>
    <affiliation>CIC-CPCET</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cic-Cpcet</name>
      <address>
        <city>Marseille</city>
        <zip>13005</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IDIBAPS</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <study_first_submitted>May 16, 2013</study_first_submitted>
  <study_first_submitted_qc>May 22, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 23, 2013</study_first_posted>
  <last_update_submitted>April 18, 2016</last_update_submitted>
  <last_update_submitted_qc>April 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

